Another Unmet Need against Residual Risk of Atherosclerotic Cardiovascular Disease: Can "Thrombin Pathway" Be a New Target for Therapy?open access

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.